• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导与转录激活因子3和磷脂酰肌醇-3激酶作为黑色素瘤细胞对糖皮质激素反应的协同调节因子。

Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones.

作者信息

Krasil'nikov Mikhail, Shatskaya Valentina

机构信息

Institute of Carcinogenesis, N.N. Blochin Cancer Research Center, Russian Academy of Medical Science, Kashirskoe shosse 24, Moscow 115478, Russia.

出版信息

J Steroid Biochem Mol Biol. 2002 Nov;82(4-5):369-76. doi: 10.1016/s0960-0760(02)00223-6.

DOI:10.1016/s0960-0760(02)00223-6
PMID:12589944
Abstract

STAT proteins act as signal transducers and activators of transcription in cells treated with cytokines or growth factors. Here we analyzed the possible cooperation between STAT3 and phosphatidylinositol-3 kinase (PI-3 kinase) and its involvement in antiproliferative signals induced by glucocorticoid hormones. Treatment of melanoma cells with dexamethasone (DEX) resulted in coexpression of STAT3 activation and increase in the PI-3 kinase protein level. Using plasmids-containing JAK2 and STAT3 constructs, we demonstrated that activation of JAK/STAT signaling led to up regulation of PI-3 kinase and enhancement of DEX's ability to increase PI-3 kinase levels in target cells. Prolonged DEX treatment of melanoma cells resulted in constitutive increases in both STAT3 and PI-3 kinase protein levels that were correlated with increased melanoma resistance to antiproliferative hormone action. Similarly, forced expression of both STAT3 and PI-3 kinase in melanoma cells led to enhanced resistance to hormone treatment. Forced expression of PI-3 kinase led to increase in STAT3 activity in a JAK-dependent manner, indicating the existence of a feedback regulatory cascade between the JAK/STAT3 and PI-3 kinase pathways. We suggest that protection of melanoma cells from antiproliferative effects of glucocorticoid hormones may be mediated, at least in part, by the constitutive activation of the STAT3/PI-3 kinase signaling pathway.

摘要

信号转导及转录激活蛋白(STAT)在经细胞因子或生长因子处理的细胞中作为信号转导子和转录激活子发挥作用。在此,我们分析了STAT3与磷脂酰肌醇-3激酶(PI-3激酶)之间可能存在的协同作用及其在糖皮质激素诱导的抗增殖信号中的作用。用地塞米松(DEX)处理黑色素瘤细胞导致STAT3激活的共表达以及PI-3激酶蛋白水平的升高。使用含有JAK2和STAT3构建体的质粒,我们证明JAK/STAT信号的激活导致PI-3激酶的上调以及DEX在靶细胞中增加PI-3激酶水平的能力增强。对黑色素瘤细胞进行长时间的DEX处理导致STAT3和PI-3激酶蛋白水平的持续性增加,这与黑色素瘤对抗增殖激素作用的抗性增加相关。同样,在黑色素瘤细胞中强制表达STAT3和PI-3激酶均导致对激素治疗的抗性增强。强制表达PI-3激酶导致STAT3活性以JAK依赖的方式增加,表明在JAK/STAT3和PI-3激酶途径之间存在反馈调节级联反应。我们认为,黑色素瘤细胞对糖皮质激素抗增殖作用的保护可能至少部分是由STAT3/PI-3激酶信号通路的组成性激活介导的。

相似文献

1
Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones.信号转导与转录激活因子3和磷脂酰肌醇-3激酶作为黑色素瘤细胞对糖皮质激素反应的协同调节因子。
J Steroid Biochem Mol Biol. 2002 Nov;82(4-5):369-76. doi: 10.1016/s0960-0760(02)00223-6.
2
Role of phosphatidylinositol-3 kinase in regulation of differential sensitivity of melanoma cells to antitumor agents. A model for hormone resistance development in tumor cells.磷脂酰肌醇-3激酶在调节黑色素瘤细胞对抗肿瘤药物的差异敏感性中的作用。肿瘤细胞中激素抵抗发展的模型。
Biochemistry (Mosc). 2004 Mar;69(3):322-30. doi: 10.1023/b:biry.0000022065.17006.7d.
3
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.JAK/STAT信号通路不足以维持干扰素抗性人黑素瘤细胞系中的抗增殖反应。
Melanoma Res. 2003 Jun;13(3):219-29. doi: 10.1097/00008390-200306000-00001.
4
ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis.细胞外信号调节激酶(ERK)和磷脂酰肌醇-3激酶(PI3K)对人黑色素瘤细胞中的信号转导及转录激活因子(STAT)转录活性具有负调控作用:对细胞凋亡致敏的意义。
Oncogene. 2003 Jun 26;22(26):4092-101. doi: 10.1038/sj.onc.1206598.
5
Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.JSI-124(葫芦素I)的发现,一种选择性的Janus激酶/信号转导及转录激活因子3信号通路抑制剂,对小鼠体内的人源和鼠源癌细胞具有强大的抗肿瘤活性。
Cancer Res. 2003 Mar 15;63(6):1270-9.
6
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.孕激素通过一种依赖于Jak和Src的机制诱导乳腺癌细胞中信号转导子和转录激活子3(Stat3)的转录激活。
Mol Cell Biol. 2005 Jun;25(12):4826-40. doi: 10.1128/MCB.25.12.4826-4840.2005.
7
Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.Janus激酶(JAK)/信号转导子和转录激活子(STAT)级联在晚期糖基化终产物诱导NRK - 49F细胞发生细胞有丝分裂中的作用
Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):231-8.
8
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.BRCA1在人前列腺癌细胞中对JAK-STAT3信号通路的组成性激活。
FEBS Lett. 2001 Jan 19;488(3):179-84. doi: 10.1016/s0014-5793(00)02430-3.
9
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.JAK抑制剂JAB/SOCS-1可选择性抑制细胞因子诱导的JAK-STAT激活,但对v-Src诱导的JAK-STAT激活无抑制作用。
Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829.
10
[The molecular mechanism responsible for the adaptation of malignant tumors to hormonal drugs: a role of phophatidylinositol-3-kinase and phosphoinositide-dependent proteins].[恶性肿瘤对激素药物适应性的分子机制:磷脂酰肌醇-3-激酶和磷脂酰肌醇依赖性蛋白的作用]
Vestn Ross Akad Med Nauk. 2004(12):20-5.

引用本文的文献

1
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.一项I期试验,评估在接受鲁索替尼和甲基泼尼松龙治疗后病情进展的复发/难治性多发性骨髓瘤患者中添加来那度胺的疗效。
Target Oncol. 2024 May;19(3):343-357. doi: 10.1007/s11523-024-01049-w. Epub 2024 Apr 20.
2
Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.Janus 激酶抑制剂芦可替尼在多发性骨髓瘤的临床前和临床评估。
Oncotarget. 2024 Feb 5;15:65-75. doi: 10.18632/oncotarget.28547.
3
Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring.
白癜风活动期患者的尿液蛋白质组学分析:用于预测和监测类固醇治疗疗效的生物标志物
Front Mol Biosci. 2022 Feb 17;9:761562. doi: 10.3389/fmolb.2022.761562. eCollection 2022.
4
Interaction of JAK with steroid receptor function.JAK与类固醇受体功能的相互作用。
JAKSTAT. 2013 Oct 1;2(4):e24911. doi: 10.4161/jkst.24911. Epub 2013 May 7.
5
NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.NF-κB/STAT3/PI3K 信号转导在 iMyc E μ B 淋巴瘤中的相互作用。
Mol Cancer. 2010 Apr 30;9:97. doi: 10.1186/1476-4598-9-97.